This inventor holds 1 USPTO granted patent and 4 published patent applications and 1 EPO patent. Top assignees: Dana-Farber-Cancer Institute Inc., Genome Research Limited, The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1,269 
1 out of 15 
1 out of 3,699 
Years Active: 2026
Title: Mathew Garnett: Inventor in Cambridge, GB.
Introduction
Mathew Garnett is an inventor associated with Cambridge, Great Britain. His work includes a patent application concerning a potential treatment approach for triple-negative breast cancer.
Latest Patents
Garnett is associated with 1 patent: “Method of Treating Triple-Negative Breast Cancer.” The disclosure describes administering oxyphenisatin, oxyphenisatin acetate, or bisacodyl, including certain pharmaceutically acceptable salts or hydrates, to treat triple-negative breast cancer. It also describes combining oxyphenisatin or bisacodyl with additional active agents and assessing whether a patient may respond to treatment.
Career Highlights
The organizations associated with Garnett include the United States of America, as represented by the Secretary of the Department of Health and Human Services, and Genome Research Limited.
Collaborations
Garnett’s listed collaborators include Vinodh Nalin Rajapakse and William Curtis Reinhold.
Conclusion
Mathew Garnett’s patent work focuses on proposed therapeutic and patient-response approaches for triple-negative breast cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile